Satellos Bioscience Inc. Common Stock (MSLE) — Financial Flexibility Index
Satellos Bioscience Inc. Common Stock (MSLE) has a Financial Flexibility Index of -1.77x as of December 2025. Free cash flow of $-7.26 Million (operating CF $-7.26 Million minus capex $0.00) represents -2% of total liabilities ($4.11 Million). Also explore Satellos Bioscience Inc. Common Stock (MSLE) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Satellos Bioscience Inc. Common Stock Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Satellos Bioscience Inc. Common Stock across 5 annual periods. Check strategic asset allocation of Satellos Bioscience Inc. Common Stock to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Satellos Bioscience Inc. Common Stock (2021–2025)
Year-by-year free cash flow to debt coverage for Satellos Bioscience Inc. Common Stock. For the full company profile including market capitalisation, see Satellos Bioscience Inc. Common Stock (MSLE) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.75x | $-23.59 Million | $-23.60 Million | $4.11 Million | ▼ -18.6% |
| 2024 | -4.84x | $-17.40 Million | $-17.40 Million | $3.59 Million | ▼ -51.8% |
| 2023 | -3.19x | $-8.72 Million | $-8.73 Million | $2.73 Million | ▼ -56.3% |
| 2022 | -2.04x | $-4.26 Million | $-4.26 Million | $2.09 Million | ▲ +14.5% |
| 2021 | -2.39x | $-3.94 Million | $-3.95 Million | $1.65 Million | — |